Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,331 across all filing types
Latest filing 2024-09-16 Major Shareholding Noti…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Notification of major shareholding
Major Shareholding Notification Classification · 98% confidence The document is titled "Standard form for notification of major holdings" and explicitly deals with the acquisition or disposal of voting rights, referencing specific articles of Directive 2004/109/EC (a European transparency directive). Section 6 and 7 detail the resulting percentage of voting rights and the total number of shares. This structure is characteristic of a notification required when an investor's stake crosses a major holding threshold. Among the provided codes, 'MRQ' (Major Shareholding Notification) is the most appropriate classification for reporting changes in significant share ownership levels that cross defined thresholds.
2024-09-16 English
Notification of major shareholding
Major Shareholding Notification Classification · 98% confidence The document text explicitly states "Notification of major shareholding" and directs the user to an attachment on an external news service (www.newsweb.no). This indicates a formal announcement regarding a change in significant ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Given the extremely short length (108 characters) and the instruction to 'See attachment', it is an announcement of the filing rather than the full filing itself, but MRQ is the most specific category for the content described.
2024-09-16 English
Photocure ASA: Results for the second quarter of 2024
Earnings Release Classification · 99% confidence The document provides detailed financial highlights, operational reviews, and management commentary specifically for the 'second quarter 2024' and compares it to the previous year's second quarter. It includes key performance indicators like revenue, EBITDA, and unit sales, presented in a structured format typical of periodic financial reporting. The content is comprehensive, covering business segments, strategic partnerships, and future guidance, which strongly indicates a formal quarterly financial report. Since it is a comprehensive report for a period shorter than a year (Q2), the appropriate classification is Interim / Quarterly Report (IR). It is not merely an Earnings Release (ER) as it contains extensive operational detail and tables, nor is it an Annual Report (10-K). Q2 2024
2024-08-07 English
Photocure ASA: Results for the second quarter of 2024
Earnings Release Classification · 99% confidence The document title is "Photocure ASA 2nd Quarter 2024 Results" and it contains detailed financial highlights for Q2 2024, including revenue, EBITDA, balance sheet information, and segment trends (North America and Europe). It also discusses strategic priorities and recent milestones related to their products (Hexvix/Cysview). This structure—a presentation summarizing period-specific financial performance—is characteristic of an Investor Presentation (IP) or potentially an Earnings Release (ER). Since the document is extensive (37,322 characters) and provides detailed operational and financial metrics beyond just the initial highlights, it aligns best with an Investor Presentation (IP) which typically accompanies or follows the formal Earnings Release. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR) in the regulatory filing sense, but rather a presentation package for investors. Q2 2024
2024-08-07 English
Photocure ASA: Results for the second quarter of 2024
Earnings Release Classification · 100% confidence The document explicitly reports the "Results for the second quarter of 2024" for Photocure ASA, detailing key financial metrics like revenues (NOK 122.4 million) and EBITDA (NOK 27.8 million) for the period. It also reiterates full-year financial guidance and discusses operational updates. This content structure—a summary of financial performance for a specific, shorter-than-annual period (Q2)—is characteristic of an Interim/Quarterly Report (IR). Although it mentions that the full financial report and presentation are enclosed/will be published, the provided text itself is the substantive earnings announcement/summary, not just a brief announcement of publication (which would suggest RPA or RNS). Since it contains the core results and management commentary for the interim period, IR is the most appropriate classification. Q2 2024
2024-08-07 English
Photocure ASA: Results for the second quarter of 2024
Earnings Release Classification · 100% confidence The document is titled "Photocure ASA: Results for the second quarter of 2024" and provides key financial metrics (revenues, EBITDA) for Q2 2024, reiterates financial guidance, and discusses operational updates. This content structure strongly indicates an initial announcement of periodic financial results, which aligns with the definition of an Earnings Release (ER). Although it mentions the full financial report and presentation will be published later, the document itself contains the core earnings highlights, making ER the most appropriate classification over RPA or RNS. The length (6943 chars) is substantial enough to contain the summary highlights. Q2 2024
2024-08-07 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.